December 16, 2016
46,988
383
168
1.17%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
3:05Now PlayingThis fall, researchers in South Africa began the largest clinical trial of a potential HIV/AIDS vaccine ever.
South Africa is home to almost a fifth of the world’s HIV-positive population. “That vicious cycle of the older men who’d infect the young girls, and the young girls would infect their peers, that perpetuates the infection,” Helen Joseph Hospital Dr. Sello Mashamaite told VICE News in Johannesburg, South Africa.
The vaccine trial, known as HVTN 702, could lead to a breakthrough in preventing new cases. Researchers expect that the vaccine will be 50 percent effective, a significant improvement from a 2009 version that was 31 percent effective.
Results from the first 5,400 recipients of the vaccine are expected in late 2020.
Read next"Trump has no policy plans for HIV/AIDS and his team has an abysmal track record"
Watch next"The fight for CRISPRThe biggest biotech discovery in decades is stuck in legal limbo"
Subscribe to VICE News here
Check out VICE News for more
Follow VICE News here:
More videos from the VICE network
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.